Keyphrases
Transfusion Requirements
100%
Hepatitis A
100%
Autoimmune Hemolytic Anemia
100%
Myelofibrosis
100%
Prednisolone
100%
Essential Thrombocythemia
100%
Polycythemia Vera
100%
Clinical Laboratory
100%
Interferon-α (IFN-α)
100%
Clinical Characteristics
100%
Recombinant Interferon
100%
Hepatitis A Virus
100%
Epstein-Barr Virus Infections
100%
Molecular Response
100%
Monotherapy
100%
Rituximab
100%
Child Hospitalized
100%
Fecal Shedding
100%
Randomized Phase III Trial
100%
Epstein-Barr Virus
100%
Interferon alpha-2b
85%
Infectious Mononucleosis
80%
Tonsillitis
60%
JAK2V617F mutation
42%
Young children
40%
Fever
40%
Lymphocytosis
40%
Age Groups
40%
Virus-neutralizing Antibody
36%
Transfusion
33%
Acute Myeloid Leukemia
33%
JAK2V617F
28%
Long-term Treatment
28%
Remission
25%
Lymphadenopathy
20%
Sore Throat
20%
Elevated Liver Enzymes
20%
Clinical Features
20%
Physical Findings
20%
Common Disease
20%
Abdominal Pain
20%
Older Age Group
20%
Young Age
20%
Copenhagen
20%
Immunocompetent child
20%
Headache
20%
Early childhood
20%
Under-five children
20%
Rare Diseases
20%
Teenagers
20%
Medicine and Dentistry
Epstein-Barr Virus Infection
100%
Myelofibrosis
100%
Polycythemia vera
100%
Essential Thrombocythaemia
100%
Epstein Barr Virus
100%
Janus Kinase
83%
Infectious Mononucleosis
66%
Tonsillitis
50%
Allele
50%
Lymphocytosis
33%
Myeloproliferative Neoplasm
33%
Toddlers
33%
Adolescence
33%
Alanine Aminotransferase
16%
Sore Throat
16%
Laboratory Test
16%
Headache
16%
Thrombosis
16%
Rhinorrhea
16%
Rare Disease
16%
Lymphadenopathy
16%
Clinical Trial
16%
Abdominal Pain
16%
Nausea
16%
Clinical Feature
16%
Lactate Dehydrogenase
16%
Elevated Transaminase
16%
Antibody
16%
Diseases
16%
Pharmacology, Toxicology and Pharmaceutical Science
Myelofibrosis
100%
Glucocorticoid
100%
Thrombocythemia
100%
Rituximab
100%
Monotherapy
100%
Polycythemia vera
100%
Prednisolone
100%
Janus Kinase
83%
Remission
55%
Adverse Event
22%
Thrombosis
16%
Clinical Trial
16%